Skip to content

Xiuzheng Pharmaceutical controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2012

    Chromium-Exceeding Medicinal Capsules Incident

    In April 2012, CCTV exposed that illegal industrial gelatin had entered the medicinal capsule supply chain, and testing found that some drug capsule batches from Xiuzheng Pharmaceutical and other companies exceeded chromium limits. After the incident, regulators investigated and punished the companies and batches involved and recalled them. This entry records only the specific batches exposed, not all Xiuzheng drugs.